MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Contributions of sensorial feedback to gait in Parkinson’s disease

    F.A. Barbieri, L.T.B. Gobbi, P.C.R. Santos, R. Vitório, L. Simieli, D. Orcioli-Silva, M.B. Pestana, C.M. Fiorelli, Q. Almeida (Bauru, Brazil)

    Objective: To evaluate the integration of optic flow and proprioception when people with Parkinson's disease (PD), under and without dopaminergic medication effects, and matched-control group…
  • 2016 International Congress

    Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease

    C.J.H.M. Klemann, G. Poelmans, G.J.M. Martens, J.E. Visser (Nijmegen, Netherlands)

    Objective: To increase our understanding of how physical exercise may drive adaptive neuroplasticity in a mouse model of Parkinson's disease (PD). Background: PD is a…
  • 2016 International Congress

    Acute admissions in people with Parkinson’s – More than just frailty

    N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)

    Objective: Review if admissions of People with Parkinson's(PwP) to hospital is directly related to their Parkinson's symptoms. Assess if medications are received on time. Explore…
  • 2016 International Congress

    Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease

    A. Turakhonov, S. Dadajonov, R. Sadikov, R. Khodjaev, S. Nurov (Tashkent, Uzbekistan)

    Objective: Our primary aim was to study the effect of beta - blockers on the dynamics of extrapyramidal disorders in patients suffering from coronary heart…
  • 2016 International Congress

    Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results

    S. Mezzarobba, M. Grassi, M. Catalan, L. Pellegrini, R. Valentini, B. Krüger, P. Manganotti, P. Bernardis (Trieste, Italy)

    Objective: To evaluate the effects of a novel experimental protocol to treat patients with Parkinson's disease (PwP) and freezing of gait (FoG), using functional, and…
  • 2016 International Congress

    Apraclonidine in the treatment of ptosis

    S. Wijemanne, D. Vijayakumar, J. Jankovic (Houston, TX, USA)

    Objective: To describe the improvement in ptosis with apraclonidine in patients with botulinum toxin (BoNT) induced ptosis. Background: Ptosis is a manifestation of a variety…
  • 2016 International Congress

    Subthalamic nucleus deep brain stimulation modulate catecholamine levels with significant relations to clinical outcome after surgery in patients with Parkinson’s disease

    T. Yamamoto, T. Uchiyama, Y. Higuchi, M. Asahina, S. Hirano, Y. Yamanaka, S. Kuwabara (Chiba, Japan)

    Objective: Because subthalamic nucleus deep brain stimulation is effective in L-3,4-dihydroxyphenylalanine responsive patients with Parkinson's disease (PD), the preoperative catecholamine levels may affect the effect…
  • 2016 International Congress

    Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone

    J. Runge, A. Wloch, M. Abdallad, M. Manu, J.K. Krauss (Hannover, Germany)

    Objective: Since a few years rechargeable pacemaker technology is available in deep brain stimulation. This technical innovation becomes more and more important in clinical practice,…
  • 2016 International Congress

    Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets

    N. Bukhari, B.H. Kopell, R.A. Ramdhani (New York, NY, USA)

    Objective: To demonstrate the role of contact polarity on therapeutic impedances at two DBS targets. Background: Neuromodulation with DBS is an established therapy for medically…
  • 2016 International Congress

    Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle

    T. Musacchio, M. Rebenstorff, F. Fluri, C. Kleinschnitz, J.M. Brotchie, J. Volkmann, J.B. Koprich, C.W. Ip (Würzburg, Germany)

    Objective: To determine if subthalamic nucleus (STN)-deep brain stimulation (DBS) leads to a measurable functional improvement of motor deficits in an AAV1/2 A53T α-synuclein (aSyn)…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley